Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Mem. Inst. Oswaldo Cruz ; 113(2): 135-137, Feb. 2018.
Article in English | LILACS | ID: biblio-1040589

ABSTRACT

The yellow fever (YF) vaccine has been used since the 1930s to prevent YF, which is a severe infectious disease caused by the yellow fever virus (YFV), and mainly transmitted by Culicidae mosquitoes from the genera Aedes and Haemagogus . Until 2013, the World Health Organization (WHO) recommended the administration of a vaccine dose every ten years. A new recommendation of a single vaccine dose to confer life-long protection against YFV infection has since been established. Recent evidence published elsewhere suggests that at least a second dose is needed to fully protect against YF disease. Here, we discuss the feasibility of administering multiple doses, the necessity for a new and modern vaccine, and recommend that the WHO conveys a meeting to discuss YFV vaccination strategies for people living in or travelling to endemic areas.


Subject(s)
Humans , Yellow Fever/prevention & control , Yellow fever virus/immunology , Immunization Schedule , Antibodies, Neutralizing/immunology , Yellow Fever Vaccine/administration & dosage , Yellow Fever Vaccine/immunology
2.
Mem. Inst. Oswaldo Cruz ; 100(8): 833-839, Dec. 2005. ilus, mapas, tab
Article in English | LILACS | ID: lil-419948

ABSTRACT

The detection of dengue virus serotypes from Aedes aegypti in Manaus, state of Amazonas was carried out using the reverse transcription-polymerase chain reaction technique. Fourteen pools out 82 (17.1 percent) were positive for DENV3, providing a minimal infection rate of 2.1 percent of all analyzed infected female specimens of three different areas of the city.


Subject(s)
Animals , Female , Humans , Male , Aedes/virology , Dengue Virus/classification , Insect Vectors/virology , Brazil/epidemiology , Dengue Virus/genetics , Dengue Virus/isolation & purification , Dengue/epidemiology , Dengue/transmission , Dengue/virology , Reverse Transcriptase Polymerase Chain Reaction , Serotyping
3.
Mem. Inst. Oswaldo Cruz ; 97(3): 307-311, Apr. 2002. ilus
Article in English | LILACS | ID: lil-307965

ABSTRACT

The Mojuí dos Campos virus (MDCV) was isolated from the blood of an unidentified bat (Chiroptera) captured in Mojuí dos Campos, Santarém, State of Pará, Brazil, in 1975 and considerated to be antigenically different from other 102 arboviruses belonging to several antigenic groups isolated in the Amazon region or another region by complement fixation tests. The objective of this work was to develop a morphologic, an antigenic and physicochemical characterization of this virus. MDCV produces cytopathic effect in Vero cells, 24 h post-infection (p.i), and the degree of cellular destruction increases after a few hours. Negative staining electron microscopy of the supernatant of Vero cell cultures showed the presence of coated viral particles with a diameter of around 98 nm. Ultrathin sections of Vero cells, and brain and liver of newborn mice infected with MDCV showed an assembly of the viral particles into the Golgi vesicles. The synthesis kinetics of the proteins for MDCV were similar to that observed for other bunyaviruses, and viral proteins could be detected as early as 6 h p.i. Our results reinforce the original studies which had classified MDCV in the family Bunyaviridae, genus Bunyavirus as an ungrouped virus, and it may represent the prototype of a new serogroup


Subject(s)
Animals , Mice , Bunyaviridae , Chiroptera , Brazil , Bunyaviridae , Bunyaviridae Infections , Chlorocebus aethiops , Protein Kinases , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL